Molina Healthcare Surges 5.7% as Major Banks Raise Price Targets

Key Facts

Molina Healthcare shares surged 5.7% to reach $189.44 following a wave of price target upward revisions by five major Wall Street firms. Financial institutions including Truist Securities, UBS, Wells Fargo, Morgan Stanley, and Barclays adjusted their price targets to a new average of $165. Despite the positive price action, analysts largely maintained neutral or negative ratings, reflecting a cautious stance on the company's long-term outlook. This discrepancy between higher price targets and conservative ratings suggests a complex valuation environment for the healthcare provider. Investors are closely monitoring the stock's performance as the new average target remains below the current market price. Such analyst revisions typically trigger moderate volatility in large-cap healthcare stocks as the market recalibrates expectations.